Denileukin diftitox is under clinical development by Citius Oncology and currently in Pre-Registration for Mycosis Fungoides.

ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Mycosis Fungoides. According to GlobalData, Phase I drugs for Mycosis Fungoides have an 85% phase transition ...

The most common type of CTCL is mycosis fungoides (MF). Mycosis fungoides was so named by a French dermatologist in the 1800s due to the mushroom like tumors that developed on the skin of a ...

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. It is characterized by malignant T-cell lymphocytes in the skin. It presents as patch, plaque, or tumor stage and is ...

Considering taking supplements to treat mycosis fungoides? Below is a list of common natural remedies used to treat or reduce the symptoms of mycosis fungoides. Follow the links to read common ...

Fungal infections, aka mycosis, are conditions caused by fungi. These infections are pretty common, and while many are not deemed to be serious health threats, others can be a cause for concern.

Marshall Davies, from Dawley, was diagnosed in April 2023 with folliculotropic mycosis fungoides, a rare and potentially ...

Mycosis fungoides is a T-cell lymphoma characterized by several types of skin manifestations. It starts as red, scaly patches, often mimicking such benign conditions as eczema or psoriasis.

The TELLOMAK study addresses an unmet need for patients with advanced-stage CTCL, particularly Sezary syndrome and mycosis fungoides, who often experience debilitating symptoms such as severe ...

Ultraviolet (UV) light therapy, also known as phototherapy, is a widely used medical intervention for various skin disorders, including psoriasis, eczema, vitiligo, mycosis fungoides and atopic ...